DoubleTree Bethesda
Bethesda, MD
December 12-13, 2019
Join scientists from around the world as we continue the open discussion and constructive exchange of ideas begun in 2015 to harmonize the requirements for bioequivalence assessment.
The AAPS/EUFEPS Global Bioequivalence Harmonization Initiative: 4th International Workshop, December 12-13, 2019, serves as an ideal platform for scientists from the pharmaceutical industry and academia to voice their experience and views with regulators.
Participants will:
- Receive session summaries from the previous conference and have opportunity to provide additional input
- Get an overview of similarity/differences in bioequivalence considerations for implants/long-acting injectables
- Find out current bioequivalence requirements for orally inhaled products
- Discuss the necessity—pro or con—of bioequivalence studies for immediate release oral dosage forms
- Discover how to design complex bioequivalence programs that would be viewed positively across major regulatory regions
View workshop details and register today. Early registration deadline is November 11.